Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Microbix and Gensia Sicor terminate licensing agreement

Dec. 2, 1998

Preclinical studies of XV-454 support further testing of novel fibrinogen antagonist

Dec. 1, 1998

Searle revises OPUS-TIMI 16 trial evaluating orbofiban acetate

Nov. 25, 1998

Two new antiplatelet agents marketed in Germany

Nov. 23, 1998

Synthelabo discloses orally active human thrombin inhibitors

Nov. 18, 1998

PARAGON A establishes effective dose of lamifiban in unstable angina

Nov. 17, 1998

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Nov. 16, 1998

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Nov. 16, 1998

First IND filed by Avigen for hemophilia B gene therapy

Nov. 12, 1998

LY-203638 has potent profibrinolytic effects in canine model of thrombosis

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...